Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 676525-77-2 | MDL No. : | MFCD27952560 |
Formula : | C40H40F6IrN4P | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VCIVELSSYHAWGC-UHFFFAOYSA-N |
M.W : | 913.95 | Pubchem ID : | 60146995 |
Synonyms : |
|
Num. heavy atoms : | 52 |
Num. arom. heavy atoms : | 24 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 201.44 |
TPSA : | 53.86 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -2.19 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 13.64 |
Log Po/w (WLOGP) : | -7.44 |
Log Po/w (MLOGP) : | 5.26 |
Log Po/w (SILICOS-IT) : | 4.87 |
Consensus Log Po/w : | 3.26 |
Lipinski : | 2.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 3.0 |
Bioavailability Score : | 0.17 |
Log S (ESOL) : | -14.31 |
Solubility : | 0.0 mg/ml ; 0.0 mol/l |
Class : | Insoluble |
Log S (Ali) : | -14.84 |
Solubility : | 0.0 mg/ml ; 0.0 mol/l |
Class : | Insoluble |
Log S (SILICOS-IT) : | -8.92 |
Solubility : | 0.00000109 mg/ml ; 0.0000000012 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 6.41 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77% | Stage #1: at 150℃; for 15 h; Inert atmosphere |
A magnetically stirred suspension of 4,4’-di-tert-butyl-2,2’-dipyridyl (118 mg, 0.44 mmol) and tetrakis(2-phenylpyridine-C2,N’)(μ-dichloro)-diiridium (214 mg, 0.2 mmol) in 10 mL of 1,2-ethanediol under nitrogen was heated to 150 °C. The mixture was kept at this temperature for 15h. All the solids dissolved to yield a clear, yellow solution. After cooling the mixture to room temperature, 150 mL of water was added. The excess of bipyridine ligand was removed through three extractions with diethyl ether (50 mL), and the aqueous layer was subsequently heated to 60-70 °C. NH4PF6 (1 g) in 10 mL of water was added, and the PF6 salt of the chromophore immediately precipitated. After cooling the suspension to 5 °C, the yellow solid was separated through filtration, dried, and recrystallized through acetonitrile/ether diffusion. Yield: 280 mg (77percent). |
66% | Stage #1: at 150℃; for 15 h; Inert atmosphere |
Synthesis of [Ir(ppy)2(dtbbpy)](PF6) was adapted from literature procedures6 for the analogousunsubstituted complex. A stirred suspension of 4,4-di-tert-butyl-2,2-dipyridyl (0.44 g, 0.88mmol) and tetrakis(2-phenylpyridine-C,N)(µ-dichloro)diiridium, A (0.428g, 0.400 mmol) in 20mL of 1,2-ethanediol under nitrogen was heated to 150 °C for 15 h. All the solids dissolved toyield a clear, yellow solution. After cooling the mixture to room temperature, 200 mL of waterwere added. The excess of the bipyridine ligand was removed through three extractions withdiethyl ether (3 × 50 mL), and the aqueous layer was subsequently heated to 70 °C. NH4PF6 (2 g)in 20 mL of water was added, and the PF6 salt of the iridium complex immediately precipitated.After cooling the suspension to 5 °C, the yellow solid was separated through filtration, dried, andrecrystallized through acetonitrile/ether. Yield: 0.50 g (66percent). 1H NMR (acetone-d6, 400 MHz):δ 8.88 (d, J =2.0 Hz, dtb-bpy-H3, 2H), 8.24 (ppy-H6, pyridine, 2H, d, J = 8), 7.99-7.93 ( m,dtb-bpy-H6, 2H, ppy-H5, pyridine, 2H), 7.90 (ppy-H3, phenyl, 2H, dd, J = 7.2, 0.8 Hz), 7.79(ppy-H6, phenyl, 2H, d, J = 6 Hz), 7.71 (dtb-bpy-H5, 2H, dd, J = 6.0, 2.0 Hz), 7.14 (ppy-H4,pyridine, 2H, dt, J = 7.2, 1.6 Hz), 7.04 (ppy-H4, phenyl, 2H, dt, J= 7.6, 0.8 Hz), 6.91 (ppy-H5,phenyl, 2H, dt, J = 6.8, 1.2 Hz), 6.34 (ppy-H3, pyridine, 2H, d, J = 8), 1.42 (18H, s).HRMS (ESI) m/z calculated for C40H40N4Ir+ ([M - PF6]+) 769.2876, found 769.2866. |
[ 2757085-01-9 ]
[4,4'-Bis-trifluoromethyl]bis[(4-fluorophenyl)pyridine]iridium(III) hexafluorophosphate
Similarity: 0.84